SCHEMBL19615364

SCHEMBL19615364

CCOC(=O)c1nn(CCOC)c(CBr)c1Br

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.36
RAB9A P51151 5/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.35
MAPT P10636 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 1/20 0.35
POLB P06746 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
GAA P10253 1/20 0.34
TSHR P16473 1/20 0.34
ELANE P08246 2/20 0.33
ESR1 P03372 1/20 0.32
SMAD3 P84022 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19635863 0.85 MAPT (0.40) NPC1RAB9AHSD17B10KDM4ETP53
SCHEMBL29291187 0.83 HCAR3 (0.36) NPC1RAB9AHPGDMAPTSMN1; SMN2
SCHEMBL19615245 0.81 KMT2A (0.44) RAB9AHSD17B10KDM4ETP53MAPT
SCHEMBL19615850 0.80 ALDH1A1 (0.39) NPC1RAB9AHSD17B10KDM4ETP53
SCHEMBL19615387 0.75 SMN1; SMN2 (0.40) NPC1RAB9AHSD17B10KDM4ETP53
SCHEMBL19615264 0.73 ALDH1A1 (0.40) NPC1RAB9AHSD17B10KDM4ETP53
SCHEMBL731061 0.73 ALDH1A1 (0.34) NPC1RAB9AHSD17B10KDM4ETP53
SCHEMBL1740722 0.70 ALDH1A1 (0.39) NPC1RAB9AKDM4EHPGDMAPT
SCHEMBL15882325 0.70 ELANE (0.61) KDM4ERXFP1ELANE
SCHEMBL19615376 0.70 L3MBTL1 (0.41) HSD17B10KDM4EHPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11492358-B1 Macrocyclic indole derivatives THE BROAD INSTITUTE, INC. (US) 2022-11-08 US disclosed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 EP disclosed
EP-3458459-B1 MACROCYCLIC INDOLE DERIVATIVES BAYER AG (DE) 2022-04-27 EP disclosed
CN-109715632-B Macrocyclic indole derivatives 拜尔公开股份有限公司 2021-10-26 CN disclosed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 US disclosed
US-10981932-B2 Macrocyclic indole derivatives BAYER AKTIENGESELLSCHAFT (DE) 2021-04-20 US disclosed
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-03-19 US disclosed
EP-3458459-A1 MACROCYCLIC INDOLE DERIVATIVES Bayer Aktiengesellschaft (DE) 2019-03-27 EP disclosed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 WO disclosed
WO-2017198341-A1 MACROCYCLIC INDOLE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 2017-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11492358-B1 Macrocyclic indole derivatives CCND2, CCNT2, IDO1 NPC1 1636/4885RAB9A 2496/4885HSD17B10 2812/4885
US-10981932-B2 Macrocyclic indole derivatives CCND2, IDO1, CCNT2 NPC1 1619/4885RAB9A 2157/4885HSD17B10 2833/4885
US-20200087322-A1 MACROCYCLIC INDOLE DERIVATIVES CCND2, CCNA1, CCNT2 NPC1 2019/4885RAB9A 2378/4885HSD17B10 2894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.